tiprankstipranks
Trending News
More News >
Pola Orbis Holdings Inc. (JP:4927)
:4927
Advertisement

Pola Orbis Holdings (4927) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4927

Pola Orbis Holdings

(4927)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
¥1,444.00
▲(7.76% Upside)
Pola Orbis Holdings has a stable financial position with strong gross margins and a robust balance sheet, but faces challenges in revenue growth and profitability. Technical indicators suggest a neutral trend with no strong momentum. The stock appears overvalued based on its P/E ratio, though the dividend yield provides some compensation. Overall, the company is in a stable position but should focus on enhancing profitability and growth.

Pola Orbis Holdings (4927) vs. iShares MSCI Japan ETF (EWJ)

Pola Orbis Holdings Business Overview & Revenue Model

Company DescriptionPola Orbis Holdings (4927) is a Japan-based company primarily engaged in the cosmetics and beauty industry. The company operates through various segments, including the manufacture and sale of skincare, makeup, and fragrance products. Pola Orbis Holdings encompasses well-known brands such as Pola, Orbis, and Jurlique, catering to diverse consumer preferences and beauty trends both domestically and internationally.
How the Company Makes MoneyPola Orbis Holdings generates revenue mainly through the sale of its beauty and personal care products across multiple channels, including direct sales, retail outlets, and online platforms. The company has a strong presence in Asia, leveraging both its established brands and innovative product lines to attract a wide customer base. Key revenue streams include sales from skincare and cosmetics, as well as premium products targeted at the luxury segment. Additionally, Pola Orbis Holdings benefits from strategic partnerships and collaborations that enhance brand visibility and distribution, contributing to its overall earnings growth.

Pola Orbis Holdings Financial Statement Overview

Summary
Pola Orbis Holdings demonstrates a solid financial foundation with strong gross margins and a robust balance sheet characterized by low leverage and high equity. However, the company faces challenges in revenue growth and profitability, as evidenced by declining net profit margins and negative revenue growth. Cash flow improvements are notable, but managing capital expenditures and financing strategies will be crucial for sustained financial health.
Income Statement
70
Positive
The income statement shows a mixed performance. Gross profit margin remains strong at approximately 81.3% for 2024, indicating effective cost control and pricing strategy. However, the net profit margin for 2024 is relatively low at around 5.5%, down from 5.6% in 2023, suggesting potential challenges in converting revenue into profit. Revenue growth is negative at -1.7% in 2024, compared to a decline of -1.1% in 2023, reflecting a potential slowdown in sales growth. EBIT and EBITDA margins have also declined slightly, indicating a decrease in operational efficiency.
Balance Sheet
80
Positive
The balance sheet remains robust with a low debt-to-equity ratio of approximately 0.01, highlighting minimal leverage and financial risk. The equity ratio is high at about 82.3%, showcasing a strong capital base. Return on equity for 2024 is modest at 5.6%, reflecting a need for improved profitability. Overall, the company's financial position is stable with ample cash reserves, although profitability could be enhanced.
Cash Flow
75
Positive
Cash flow analysis indicates improvement in free cash flow, rising significantly in 2024 from a deficit in 2023. The operating cash flow to net income ratio is strong at 2.82, suggesting effective cash generation relative to reported profits. The free cash flow to net income ratio is favorable at 1.94, indicating strong cash conversion. However, fluctuations in capital expenditures and financing activities highlight potential areas of concern for long-term cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue169.78B170.36B173.30B166.31B178.64B176.31B
Gross Profit137.78B138.51B142.08B135.27B149.92B146.33B
EBITDA17.96B22.17B23.18B21.27B25.09B16.51B
Net Income6.43B9.29B9.66B11.45B11.73B4.63B
Balance Sheet
Total Assets195.94B200.32B201.21B205.94B208.04B203.74B
Cash, Cash Equivalents and Short-Term Investments60.75B64.08B65.14B81.31B92.57B85.10B
Total Debt41.00M2.12B1.69B1.88B2.28B2.44B
Total Liabilities32.24B35.41B32.81B34.48B34.77B33.89B
Stockholders Equity163.68B164.89B168.05B171.17B173.05B169.71B
Cash Flow
Free Cash Flow0.0018.01B-1.81B4.15B16.63B15.94B
Operating Cash Flow0.0026.18B14.42B15.55B23.83B23.39B
Investing Cash Flow0.00-12.10B-18.73B-12.37B-2.17B-3.34B
Financing Cash Flow0.00-13.38B-12.38B-12.67B-9.10B-27.13B

Pola Orbis Holdings Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1340.00
Price Trends
50DMA
1322.49
Positive
100DMA
1307.13
Positive
200DMA
1299.00
Positive
Market Momentum
MACD
2.85
Negative
RSI
53.05
Neutral
STOCH
62.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4927, the sentiment is Positive. The current price of 1340 is above the 20-day moving average (MA) of 1331.17, above the 50-day MA of 1322.49, and above the 200-day MA of 1299.00, indicating a bullish trend. The MACD of 2.85 indicates Negative momentum. The RSI at 53.05 is Neutral, neither overbought nor oversold. The STOCH value of 62.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4927.

Pola Orbis Holdings Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
¥151.48B19.925.10%-1.63%1.81%
68
Neutral
$297.77B46.333.99%3.88%-0.89%-34.14%
66
Neutral
$419.99B20.497.29%1.87%1.29%4.72%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
$345.44B115.341.11%2.38%2.82%-79.45%
57
Neutral
$387.13B32.895.72%1.95%-6.64%-13.78%
56
Neutral
¥1.05T-808.821.97%-3.60%-112.93%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4927
Pola Orbis Holdings
1,325.50
-105.80
-7.39%
JP:4967
Kobayashi Pharmaceutical Co
5,271.00
-142.18
-2.63%
JP:4922
Kose
5,810.00
-1,866.02
-24.31%
JP:4912
Lion
1,532.00
-167.18
-9.84%
JP:4911
Shiseido Company,Limited
2,536.50
-388.17
-13.27%
JP:4928
Noevir Holdings Co., Ltd.
4,410.00
-343.38
-7.22%

Pola Orbis Holdings Corporate Events

Pola Orbis Holdings Reports Mixed Financial Results for First Half of 2025
Aug 6, 2025

Pola Orbis Holdings reported a slight decline in net sales for the first half of fiscal 2025, with a 0.7% decrease compared to the previous year. Despite this, the company saw a 12.3% increase in operating income, although ordinary income and profit attributable to owners of the parent decreased significantly by 43.5% and 38.1%, respectively. The company’s performance forecast for the full fiscal year 2025 anticipates a modest growth in net sales and operating income, but a decline in ordinary income and profit attributable to owners. The equity ratio improved slightly, indicating a stable financial position, while the dividend forecast remains unchanged, reflecting a cautious yet optimistic outlook for stakeholders.

The most recent analyst rating on (JP:4927) stock is a Hold with a Yen1450.00 price target. To see the full list of analyst forecasts on Pola Orbis Holdings stock, see the JP:4927 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 01, 2025